Salidroside can protect against ferroptosis in cardiomyocytes and may be related to the regulation of GGT1
Journal: Frontiers in Pharmacology
Year: 2025

These findings establish GGT1 as a pivotal therapeutic target for SAL's cardioprotection, providing a mechanistic basis for its clinical application in ferroptosis-associated cardiovascular diseases.